Filter
360
Text search:
guidelines
for
pharmacovigilance
Featured
Recommendations
49
New Publications
119
Language
Document type
No document type
198
Guidelines
62
Studies & Reports
41
Strategic & Response Plan
22
Manuals
18
Training Material
6
Fact sheets
6
Situation Updates
4
Resource Platforms
1
Infographics
1
Online Courses
1
Countries / Regions
Kenya
22
Uganda
14
Ghana
13
India
13
Western and Central Europe
13
Nigeria
12
South Africa
11
Ethiopia
10
Namibia
10
Eastern Europe
10
Nepal
9
Global
9
Sierra Leone
7
Zambia
7
Tanzania
7
Rwanda
7
Malawi
7
Cambodia
5
South–East Asia Region
5
Latin America and the Carribbean
5
Liberia
4
Senegal
4
Bangladesh
4
Zimbabwe
3
Botswana
3
Lesotho
3
West and Central Africa
3
Africa
3
Russia
3
Haiti
2
Philippines
2
Indonesia
2
Mozambique
2
Sudan
2
Eswatini/ Swaziland
2
Brazil
2
Myanmar / Burma
2
East and Southern Africa
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Asia
2
Congo, Democratic Republic of
1
Morocco
1
Cameroon
1
Pakistan
1
Jordan
1
Afghanistan
1
Lebanon
1
Syria
1
Thailand
1
Gambia
1
Benin
1
Argentina
1
Ukraine
1
Libya
1
Sri Lanka
1
Yemen
1
Western Pacific Region
1
Paraguay
1
Bhutan
1
Southern Africa
1
Laos
1
Georgia
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
183
Clinical Guidelines
51
Public Health
11
Capacity Building
7
Pharmacy & Technologies
7
Women & Child Health
6
Key Resources
3
Toolboxes
TB
48
Pharmacy
44
AMR
31
COVID-19
21
HIV
20
NTDs
13
NCDs
4
Rapid Response
3
Refugee
2
Caregiver
2
Planetary Health
2
Ebola
1
Cholera
1
Polio
1
Specific Hazards
1
Evaluation report
April 2013
Evaluation report
This report is part of the overall Ukrainian National AIDS programme evaluation conducted
in September 2012
Technical Update
HIV Treatment
July 2017
The Kenyan Health Sector has been playing a critical role in
providing health care services in response to the population
needs in line with the Kenya Health Policy, 2014-2030’s goal
of attaining the highest possible health standards in a manner
responsive to the population needs.
The World Health Organization's fourth Country Cooperation Strategy 2022-2026 is an outcome of a consultative process with inputs from the Ministry of Health, various agencies in the health sector, and other relevant stakeholders. It has been developed to provide strategic direction and support towa
...
В дорожной карте по борьбе с забытыми тропическими болезнями на 2021–2030 гг. («дорожная карта») определены глобальные цели и основные этапы в отношении борьбы с 20 бол
...
This report presents an overview of the transition process in Azerbaijan, some sustainability aspects and challenges stemming from donor withdrawal from TB-related activities, along with recommendations on how to overcome transition-related difficulties and ensure sustainability.
Drug registration in Kenya started in 1982; the process mainly involves an evaluation committee at the Kenya Pharmacy and Poisons Board (PPB) that aims to approve products based on quality, safety and efficacy.
Copenhagen, Denmark, 7–8 March 2017. Meeting report
Vaccins antirabiques: Note de synthèse de l’OMS – avril 2018
Weekly epidemiological record / Relevé épidémiologique hebdomadaire
20 APRIL 2018, 93th YEAR / 20 AVRIL 2018, 93e ANNÉE
Weekly epidemiological record / Relevé épidémiologique hebdomadaire
20 APRIL 2018, 93th YEAR / 20 AVRIL 2018, 93e ANNÉE
COVID-19 Vaccines: 1 Safety Surveillance 2 Manual
While there is no indication that pregnant women have an increased susceptibility to infection with SARS-CoV-2, there is evidence that pregnancy may increase the risk of severe illness and mortality from COVID-19 disease in comparison with non-pregn
...
J Glob Health Sci. 2020 Jun;2(1):e3. A group of enzootic and zoonotic protozoan infections, the leishmaniases constitute among the most severely neglected tropical diseases (NTDs) and are found in all continents except Oceania. Representing the most common infectious diseases, NTDs comprise an open-
...
International Journal of Infectious Diseases 32 (2015) 111–117
17–24 November 2015
Global UNIDO Project: Strengthening the local production of essential generic drugs in the least developed and developing countries
